Huiyi ZHu; Xinmin Duan; Wei Cao; Lianfeng Lu; Xiaojing Song; Ting Zhu; Yang Han*; TaishengLi ;
时间:2024.04.10 发布来源:本站原创
Huiyi ZHu; Xinmin Duan; Wei Cao; Lianfeng Lu; Xiaojing Song; Ting Zhu; Yang Han*; TaishengLi ; Raltegravir Plus Nucleoside Reverse-Transcriptase Inhibitor (NRTI) Plus Lopinavir, NRTIsPlus Lopinavir for Second-Line Treatment of HIV: 96-Week Follow-up Results from a RandomizedControlled Trial, J. Biol. Regul. Homeost. Agents, 2023, 37(10): 5247-5256 (共通讯一 )